WHAT ABOUT USING SNIFFIN’ STICKS 12 SCREENING TEST TO IDENTIFY POST-COVID-19 OLFACTORY DISORDERS?
| Autor: | Auriane Gros, Elisa Demonchy, Florence Askenazy, Nicolas Guevara, Grégoire D'Andréa, Alexandra Plonka, Valeria Manera, Magali Payne, Clair Vandersteen, K. Risso, Laurent Castillo, David Chirio, Louise Emilie Dumas |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
endocrine system
medicine.medical_specialty medicine.diagnostic_test Coronavirus disease 2019 (COVID-19) Screening test business.industry Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) fungi ENT department Physical examination Sequela medicine.disease Sugar intake Internal medicine medicine Sniffin sticks business |
| Popis: | BackgroundOlfactory impairment is a major sequela of SARS-CoV-2 infection and has a negative impact on daily life quality. Olfactory loss can be assessed in many ways but seems to be little realized in a daily clinical practice. The sniffin Sticks test – 12 items (SST-12) can be used in quick olfactory disorders screening. Its use in a post-covid19 situation was the main objective of this work.MethodologyConsecutive patients consulting to the ENT department with post-Covid-19 olfactory loss were included. The clinical examination included an analog scale for the self-assessment of olfactory recovery (VAS), self-reported salt and sugar intake, a nasofibroscopy, the complete Sniffin’ Stick Test (SST) and the SST-12.ResultsAmong the 54 patients included, based on the SST-12, 14,8% (n=8) of the patients could be classified as normosmic (SST-12≥11), 48,1% (n=26) as hyposmic (6< SST-12ConclusionsSST-12 is a reliable way to screen post-COVID-19 olfactory disorders could be used in a daily clinical practice and might be used to prevent bad diet habits and so cardiovascular risk. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|